rs118203614
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_000368.5(TSC1):c.1998-1G>T variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000368.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC1 | ENST00000298552.9 | c.1998-1G>T | splice_acceptor_variant, intron_variant | Intron 15 of 22 | 1 | NM_000368.5 | ENSP00000298552.3 | |||
TSC1 | ENST00000490179.4 | c.1998-1G>T | splice_acceptor_variant, intron_variant | Intron 16 of 23 | 3 | ENSP00000495533.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tuberous sclerosis 1 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in an individual with a TSC1-related disease, but has been reported in an individual affected with tuberous sclerosis complex in the Leiden Open-source Variation Database (PMID: 21520333) and in a family diagnosed with tuberous sclerosis complex (Invitae). This sequence change affects an acceptor splice site in intron 15 of TSC1. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1998-1G>T intronic variant results from a G to T substitution one nucleotide upstream from coding exon 14 of the TSC1 gene. This variant has been reported in a patient with tuberous sclerosis complex (TSC) (Luo C et al. Orphanet J Rare Dis, 2022 Jul;17:288). Alterations that disrupt the canonical splice site are expected to result in aberrant splicing. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and may result in the creation or strengthening of a novel splice acceptor site. A resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNAdecay; although, direct evidence is unavailable. This nucleotide position is highly conserved in available vertebrate species. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at